Imunon Exchanges $1.2M of Debt for Non-Convertible Series B Preferred Stock

summarizeSummary

Imunon exchanged $1.2 million of secured debt for non-convertible Series B Preferred Stock with an 8% return and restrictive covenants, reducing debt but adding senior obligations and financing constraints.

check_boxKey Events · Financing and Capital Events · IMNN

• Debt-for-Preferred Exchange

  Exchanged $1.2 million of A-1 Note principal for 120 shares of Series B Preferred Stock at $10,000 per share, reducing the A-1 Note balance.

• Series B Preferred Terms

  New preferred stock carries an 8% annual Preferred Return, a 110% optional redemption price, and is not convertible into common stock.

• Restrictive Covenants

  Covenants require Streeterville consent for new equity issuances, asset sales, reverse splits, and fundamental transactions, limiting future financing flexibility.

• Senior Liquidation Preference

  Series B Preferred ranks senior to common stock in liquidation, with a stated value of $12,000 per share plus accrued return.

auto_awesomeAnalysis · IMNN · Life Sciences

Imunon is restructuring part of its debt with Streeterville Capital by exchanging $1.2 million of the A-1 Note for 120 shares of a new Series B Preferred Stock. The new preferred carries an 8% annual return, a 110% optional redemption price, and restrictive covenants that limit future equity issuances, asset sales, and reverse splits without Streeterville's consent. This reduces near-term cash debt obligations but adds a senior liquidation preference and ongoing payment obligations, while the covenants could constrain future financing flexibility.